Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling
Nature Genetics2014Vol. 46(5), pp. 503–509
Citations Over TimeTop 1% of 2014 papers
Gillian Rice, Yoandris del Toro Duany, Emma M. Jenkinson, Gabriella Forte, Beverley Anderson, Giada Ariaudo, Brigitte Bader‐Meunier, Eileen Baildam, Roberta Battini, Michael W. Beresford, Manuela Casarano, Mondher Chouchane, Rolando Cimaz, Abigail E. Collins, Nuno Cordeiro, Russell C. Dale, Joyce Davidson, Liesbeth De Waele, Isabelle Desguerre, Laurence Faivre, Elisa Fazzi, Bertrand Isidor, Lieven Lagae, Andrew Latchman, Pierre Lebon, Chumei Li, John H. Livingston, Charles Marques Lourenço, Maria Margherita Mancardi, Alice Masurel‐Paulet, Iain B. McInnes, Manoj P. Menezes, Cyril Mignot, James O’Sullivan, Simona Orcesi, Paolo Picco, Enrica Riva, Robert A. Robinson, Diana Rodriguez, E. Salvatici, Christiaan Scott, Marta Szybowska, John Tolmie, Adeline Vanderver, Catherine Vanhulle, José Pedro Vieira, Kate Webb, Robyn Whitney, Simon G. Williams, Lynne A. Wolfe, Sameer M. Zuberi, Sun Hur, Yanick J. Crow
Related Papers
- → RHDV 3C protein antagonizes type I interferon signaling by cleaving interferon promoter stimulated 1 protein(2022)3 cited
- → Porcine Respirovirus 1 Suppresses Host Type I Interferon Production and the JAK-STAT Signaling Pathway(2023)1 cited
- → Interferon-induced gene expression in wild-type and interferon-resistant human lymphoblastoid (Daudi) cells(1986)86 cited
- → Suppression of MDA5-mediated antiviral immune responses by NSP8 of SARS-CoV-2(2020)25 cited
- → RHDV 3C protein antagonizes type I interferon signaling by cleaving interferon promoter stimulated 1 protein(2022)